Cannabis in Medicine

A primer for health care professionals

Friday February 22, 2013
2:00-6:00 pm
Washington, DC
Mayflower Renaissance Hotel
Registration

CME credits

Objectives

The objective is to present a balanced and expert overview on the clinical use of cannabinoids to an engaged audience of healthcare practitioners in mainstream hospital-clinical settings.

The lecture series will focus on the clinical and practical therapeutic potential of cannabinoids and the endocannabinoid system.

At the end of the session, participants will be able to:
1. Describe the components and functions of the endocannabinoid system
2. Understand the effects of cannabis smoking on the lung
3. Summarize the indications for existing cannabinoid therapeutic agents
4. Outline the issues in cannabinoid drug trials, including safety and efficacy issues
5. Explore and discuss attitudes towards cannabinoids in clinical use

Registration

To Register:

1.  Registration is done via the UCSF OCME Course Registration Portal.  

2. You are required to log in.  If you need to create a new account it is free and easy, please follow the instructions on their website. 

3.   Once you have logged in, find the Cannabis in Medicine course from the calendar and click "Register Now". 

NOTICE:  UCSF OCME has revised their online registration platform as of February 6, 2013.  The new system requires you to create a username and login for the CME program registration system and then find the course from their calendar.  If you encounter problems registering online please register by telephone (415-476-5808).  We apologize for any inconvenience. 

Online Advance Registration fees:
MD/Do: $125.00
Allied HCP and Physician in training: $85.00
Industry Representative: $195.00


Onsite Registration fees:
MD/DO: $150.00
Allied HCP and Physician in training: $110.00
Industry Representative: $225.00

To register as an MD/DO or Allied HCP/Physician in training you must be engaged in clinical practice and not employed by a pharmaceutical, medical device, medical education/advertising agency. If you are employed by a pharmaceutical, medical device, medical education/advertising agency please register as an Industry Representative.

Note regarding Onsite Registrations:  Please arrive at least 15 minutes in advance (by 1:45pm) to allow for your registration to be processed prior to the scheduled session start time.

Cancellations are accepted up to Feb 14 with a $30.00 cancellation fee. No refunds or cancellations after Feb 14, 2013. All cancellation refund requests should be submitted in writing to the UCSF OCME by fax, mail or email (info@ocme.ucsf.edu).

Registration is being admistered by the University of California San Francisco, Office of Continuing Medical Education. To register and pay the registration fee you will be redirected to the UCSF OCME website. Please click on the following link for the session registration pages:

Washington, DC - Friday February 22, 2013 (UCSF Course Number MMJ13001C)

If you have any questions or concerns regarding your registration or the registration process please contact:
UCSF Office of Continuing Medical Education
3333 California Street, Room 450, San Francisco, CA 94118
Phone: 415-476-4251
Fax: 415-476-0318
Registration: 415-476-5808
Registration Fax: 415-502-1795
EMail: info@ocme.ucsf.edu

AGENDA and FACULTY

2:00 pm Introduction to the Endocannabinoid System and Pulmonary Effects of Cannabis M. Ware, MD
2:40 pm Neuropsychiatric Effects of Cannabis I. Grant, MD
3:20 pm      Effects of Cannabis in Cancer and Pain Management D. Abrams, MD
4:00 pm Break  
4:10 pm Cannabis in Primary Care J. Hergenrather, MD
4:50 pm Cannabis: A Nursing Perspective ML Mathre, RN
5:20 pm Washington DC Medical Marijuana Program: Regulations and Guidelines for HCPs Washington DC, Department of Health
5:50 pm Discussion and Conclusion  

This is a jointly sponsored UCSF-CCIC activity

        

Accreditation

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of California, San Francisco School of Medicine (UCSF) and the Canadian Consortium for the Investigation of Cannabinoids (CCIC). UCSF is accredited by the ACCME to provide continuing medical education for physicians.

UCSF designates this educational activity for a maximum of 2.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Steering Committee

Donald Abrams, MD
Professor of Clinical Medicine at the UCSF, Chief of Hematology/Oncology at San Francisco General Hospital

Jeffrey Hergenrather, MD
General Practice, Sebastopol CA

Donald Tashkin, MD
Emeritus Professor of Medicine, Medical Director of the Pulmonary Function Laboratory, David Geffen School of Medicine, University of California Los Angeles

Mark A. Ware, MBBS MRCP MSc
Associate Professor of Anesthesia and Family Medicine at McGill University, Director of Clinical Research, Pain Centre, Montreal General Hospital, Montreal, Canada

Venue

Mayflower Renaissance Hotel, Washington, DC
1127 Connecticut Avenue NW · Washington, District Of Columbia 20036 USA

Mayflower Hotel Website

  

Evaluations

The post program evaluation will be available as of February 22, 2013. Only session attendees who did not complete an evaluation on site should complete this questionnaire. This anonymous survey will enable attendees to rate various aspects of their session and provide feedback about the content and organization of the activity. Please contact CCIC Education Coordinator, Daniel Ziemianski (dziemianski@ccic.net) to complete your evaluation form if you did not do so onsite.